Tech Company Financing Transactions
Lypro Biosciences Funding Round
Lypro Biosciences closed a $178 thousand funding round on 9/7/2010. Investors included private investors.
Transaction Overview
Company Name
Announced On
9/7/2010
Transaction Type
Venture Equity
Amount
$177,950
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Alameda, CA 94502
USA
Alameda, CA 94502
USA
Phone
Undisclosed
Website
Email Address
Overview
Lypro Biosciences is a specialty biopharmaceutical company whose proprietary drug delivery technology increases the solubility and bioavailability of hydrophobic drugs and facilitates drug targeting to specific receptor(s).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michelle Call
Founder
Robert Ryan
VP - Bus. Development
Stephen Carroll
VP - R & D
Trudy Forte
Browse more venture capital transactions:
Prev: 9/7/2010: Intarcia Therapeutics venture capital transaction
Next: 9/7/2010: Joyent venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs